Summary for ENCSR590OZV

doi:10.17989/ENCSR590OZV

Summary

Status
released
Description
Reference epigenome for human H7-derived cardiac muscle cell
Donor diversity
single
Assay
DNase-seq, ChIP-seq
Target
H3K27me3, H3K36me3, H3K4me3
Biosample summary
Homo sapiens cardiac muscle cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 days
Diseases
Not reported
Treatments
Activin A, Bone morphogenetic protein 4, Fibroblast growth factor 2

Attribution

ENCODE3 project
Lab
ENCODE Consortium
Award
U41HG006992 (J. Michael Cherry, Stanford)
Project
ENCODE
External resources

Experiments in ENCSR590OZV

Experiments
4 experiments
Accession
Assay
Target
Biosample summary
Lab
Status
Cart
ENCSR000DSIChIP-seqH3K36me3Homo sapiens cardiac muscle cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 daysJohn Stamatoyannopoulos, UW
released
ENCSR000DSMChIP-seqH3K27me3Homo sapiens cardiac muscle cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 daysJohn Stamatoyannopoulos, UW
released
ENCSR000DSPChIP-seqH3K4me3Homo sapiens cardiac muscle cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 daysJohn Stamatoyannopoulos, UW
released
ENCSR000EMYDNase-seqHomo sapiens cardiac muscle cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 daysJohn Stamatoyannopoulos, UW
released
Control experiments
1 control experiment
Accession
Control type
Biosample summary
Lab
Status
Cart
ENCSR000DSNinput libraryHomo sapiens cardiac muscle cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 daysJohn Stamatoyannopoulos, UW
released